dalteparin has been researched along with Hyperplasia in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atherosclerosis is characterized by a proliferation of vascular smooth muscle cells (VSMCs) and their migration to the intima, which induces thickening of the intima itself, but the mechanism remains poorly understood." | 1.43 | Role of parnaparin in atherosclerosis. ( Artico, M; Bonomini, F; Parnigotto, P; Rezzani, R; Rodella, LF; Taurone, S; Zamai, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meneveau, N | 1 |
| Schiele, F | 1 |
| Grollier, G | 1 |
| Farah, B | 1 |
| Lablanche, JM | 1 |
| Khalifé, K | 1 |
| Machecourt, J | 1 |
| Danchin, N | 1 |
| Wolf, JE | 1 |
| Simpson, M | 1 |
| Hak, JB | 1 |
| Bassand, JP | 1 |
| Bonomini, F | 1 |
| Taurone, S | 1 |
| Parnigotto, P | 1 |
| Zamai, L | 1 |
| Rodella, LF | 1 |
| Artico, M | 1 |
| Rezzani, R | 1 |
| Ellensen, VS | 1 |
| Abrahamsen, I | 1 |
| Lorens, J | 1 |
| Jonung, T | 1 |
| Waltham, M | 1 |
| Harris, J | 1 |
| Fletcher, JP | 1 |
| Ao, PY | 1 |
| Hawthorne, WJ | 1 |
1 trial available for dalteparin and Hyperplasia
| Article | Year |
|---|---|
Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Follow- | 2000 |
4 other studies available for dalteparin and Hyperplasia
| Article | Year |
|---|---|
Role of parnaparin in atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Disease Models, Animal; Heparin, Lo | 2016 |
Effects of enoxaparin and dalteparin on proliferation and migration of patient-derived vascular smooth muscle cells.
Topics: Adult; Aged, 80 and over; Cell Movement; Cell Proliferation; Cells, Cultured; Dalteparin; Dose-Respo | 2014 |
Intimal hyperplasia: the nemesis of cardiovascular intervention.
Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Dalteparin; Enoxaparin; Fibrinolytic Agent | 2004 |
Antiproliferative effects of low molecular weight heparin.
Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Cell Proliferation; Dalteparin; Dose-Respo | 2004 |